Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and C
- PMID: 23445306
- DOI: 10.1111/bjd.12227
Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and C
Erratum in
- Br J Dermatol. 2013 Apr;168(4):914. Al-Ri Fai, A [corrected to Al-Rifai, A]
Comment on
-
Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting.Br J Dermatol. 2013 Mar;168(3):609-16. doi: 10.1111/bjd.12045. Br J Dermatol. 2013. PMID: 22985451
-
Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient.Br J Dermatol. 2013 Mar;168(3):679-80. doi: 10.1111/bjd.12120. Epub 2013 Jan 31. Br J Dermatol. 2013. PMID: 23121260 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
